Acrivon Therapeutics Financial Ratios for Analysis 2020-2024 | ACRV

Fifteen years of historical annual and quarterly financial ratios and margins for Acrivon Therapeutics (ACRV).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2023202220212020
9.7520.2734.462.80
----
----
----
----
----
----
----
----
----
----
----
----
-49.83-18.2868.2263.07
-49.83-18.28-16.46-423.13
-43.68-17.20-15.24-242.84
-49.83-18.28-16.46-423.13
5.387.7855.800.88
-1.93-7.31-8.02-1.96
-1.99-7.83-8.16-1.97

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302020-12-31
16.1612.409.7515.5421.8421.8220.2712.31-----
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-8.70-15.27-15.89-10.47-9.33-7.95-5.2420.16-----
-8.70-15.27-15.89-10.47-9.33-7.95-5.24-11.96-----
-8.15-13.68-13.92-9.57-8.69-7.49-4.93-10.49-----
-8.70-15.27-15.89-10.47-9.33-7.95-5.24-11.96-----
6.984.775.386.256.767.327.7842.84-----
-0.86-0.76-1.93-1.37-0.93-0.52-7.31-11.68-8.05-4.760.00-5.850.00
-0.88-0.79-1.99-1.38-0.94-0.52-7.83-12.75-8.89-4.99--5.91-